Avience Biomedicals IPO GMP & Listing Price
SME · ₹208 · NSE SME
IST
GMP vs actual listing
Closed its first day at ₹414.95 (+99.5% on the issue price)
GMP was off by 20.3% on this issue. We publish every miss, not just the hits.
Subscription status
as of 25 Jun, 3:36 pmNot in our records for this issue: Sector, Lot size, Min investment, P/E ratio, Registrar.
Avience Biomedicals IPO FAQs
What was the listing price of Avience Biomedicals IPO?
Avience Biomedicals IPO listed at ₹395.2 on Thu, 25 Jun, 2026, +90.0% against the issue price of ₹208. The last grey market premium before listing was ₹145, which implied ₹353.
What was the GMP of Avience Biomedicals IPO before listing?
The last grey market premium for Avience Biomedicals IPO was ₹145, recorded at 3:36 pm IST on Thu, 25 Jun, 2026. That implied +69.7% over the ₹208 price. The stock actually listed +90.0%, so GMP was off by 20.3%.
When was Avience Biomedicals IPO allotment and listing?
The allotment date for Avience Biomedicals IPO is not announced yet and the shares listed on Thu, 25 Jun, 2026 on NSE SME.
GMP is unofficial. Grey market premium is an unregulated, over-the-counter indication with no backing from SEBI, BSE or NSE. It is not a listing-price guarantee and not investment advice. Read the RHP and consult a SEBI-registered adviser before applying.